EULAR: Etanercept Valuable for Juvenile Arthritis but New Risk ... - MedPage Today

EULAR: Etanercept Valuable for Juvenile Arthritis but New Risk ... MedPage Today, NJ Explain to interested patients that etanercept is FDA approved for adults with rheumatoid arthritis and for older children with juvenile idiopathic arthritis, but not for children under six. Explain that rare side effects of drugs are often not ...

Subclinical Markers Predict Relapse In Juvenile Idiopathic ... - Medical News Today (press release)

Subclinical Markers Predict Relapse In Juvenile Idiopathic ... Medical News Today (press release), UK Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive ...

Total Elbow Arthroplasty in Patients Forty Years of Age or Less - Journal of Bone and Joint Surgery (subscription)

Total Elbow Arthroplasty in Patients Forty Years of Age or Less Journal of Bone and Joint Surgery (subscription) The arthroplasty was performed primarily as a salvage procedure in thirteen patients (two with a bilateral arthroplasty) with rheumatoid arthritis, in seventeen patients (four with a bilateral arthroplasty) with juvenile rheumatoid arthritis, ...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited ... - PR Newswire (press release)

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited ... PR Newswire (press release), NY In June 2005, ACTEMRA was launched by Chugai in Japan as a therapy for Castleman's disease; in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also ...